Sapan Ghai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFutura Medical Share News (FUM)

Share Price Information for Futura Medical (FUM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 40.30
Bid: 40.30
Ask: 40.95
Change: -1.00 (-2.42%)
Spread: 0.65 (1.613%)
Open: 41.30
High: 41.30
Low: 40.30
Prev. Close: 41.30
FUM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: BP and Prudential help snap FTSE losing streak

Tue, 06th Feb 2024 17:04

(Alliance News) - Stock prices in London pushed higher on Tuesday, with the FTSE 100 registering its first rise in four trading days, with oil major BP the star performer.

The FTSE 100 index ended up 68.15 points, 0.9%, at 7,681.01. London's large-cap index was on a four-day losing streak ahead of Tuesday's session.

The FTSE 250 ended 152.79 points higher, 0.8%, at 19,171.34, and the AIM All-Share rose 3.80 points, 0.5%, at 754.17.

The Cboe UK 100 shot up 1.1% at 769.35, the Cboe UK 250 added 1.0% at 16,613.67, but the Cboe Small Companies faded 0.3% to 14,638.59.

In mainland Europe, the CAC 40 in Paris rose 0.7%, while the DAX 40 in Frankfurt climbed 0.7%.

In New York, the Dow Jones Industrial Average was up 0.2% at the time of the closing bell in Europe. The S&P 500 was only marginally higher, while the Nasdaq Composite was a touch lower.

The European open received some impetus after bullish trade in Asia, on policy support measures to boost beleaguered shares. Stocks exposed to China were among the better performers in London, with Asia-focused insurer Prudential up 3.8%.

There was also some better data which bolstered sentiment in Europe. The European Central Bank said that median expectations for inflation over the next 12 months decreased as it published a consumer expectation survey from December.

Median expectations for inflation over the next 12 months eased to 3.2% in December from 3.5% in November. The ECB said that this was the third consecutive month of decline.

Meanwhile, new manufacturing orders in Germany unexpectedly rose in December, according to preliminary data, marking an improvement from the previous month for Europe's largest economy.

According to Destatis, factory orders rose by 8.9% on-month in December, after being stagnant from October to November. FXStreet were expecting factory orders to be stagnant.

In the UK, the downturn in the construction sector eased slightly at the start of the year, according to a survey.

The S&P Global UK construction purchasing managers' index rose to 48.8 points in January from 46.8 points in December. This marks the highest reading since August 2023 and is higher than FXStreet market consensus of 47.3 points.

That said, the index remained below the crucial 50.0 no-change threshold for the fifth month running.

The pound was quoted at USD1.2590 late Tuesday in London, higher compared to USD1.2527 at the equities close on Monday. The euro stood at USD1.0749, up slightly against USD1.0728. Against the yen, the dollar was trading at JPY148.09, lower compared to JPY148.80.

In London, BP shares shot up 5.3%.

XTB analyst Kathleen Brooks commented: "Although 2023 full year profits were shy of estimates, the strong Q4 performance suggests that the company gathered steam at the end of last year, which is a good backdrop for 2024's performance. There was good news on gas trading and its profitable convenience line, which saw gross margins soar, the company also jumped on the AI bandwagon."

BP said it completed its USD1.5 billion share buyback on Friday, and now intends to initiate a new USD1.75 billion buyback, prior to reporting its first quarter results which are due on May 7. It intends to buy back USD3.5 billion in shares for the first half of 2024.

BP added that it plans to conduct share buybacks worth at least USD14 billion through 2025, as part of its commitment to return at least 80% of surplus cash flow to shareholders.

In 2023, revenue dropped by 14% to USD213.03 billion from USD248.89 billion in 2022. However, pretax profit jumped by 54% to USD23.75 billion from USD15.41 billion.

Renishaw surged 16%.

The Gloucestershire, England-based provider of manufacturing technologies, analytical instruments and medical devices said pretax profit fell 27% to GBP56.5 million in the six months that ended December 31 from GBP77.8 million a year before.

Revenue declined 4.9% to GBP330.5 million from GBP347.7 million a year earlier.

Despite the weaker results, Renishaw left its dividend unchanged at 16.8 pence per share.

Looking ahead, Chief Executive Officer William Lee said: "We expect an improvement in our trading performance in the second half of the financial year as market conditions improve, and as we continue to pursue a range of growth opportunities. To support our through-cycle growth strategy, we are continuing to focus on productivity and to make targeted investments in our people, our production facilities, and our new product pipeline."

Elsewhere in London, Futura Medical shares jumped 40% as it hailed its first "meaningful" from product sales.

The Guildford, Surrey-based pharmaceutical company expects to report GBP3.1 million revenue for 2023. No revenue was recognised in 2022.

Chief Executive Officer James Barder said: "I am incredibly proud to report that we have delivered on the three key objectives that we set out in 2023: achieving regulatory approval in the US; progressing commercial discussions by securing a standout distribution partner in Haleon for the largest consumer healthcare market in the world and reporting our first meaningful revenues. The delivery of this progress, alongside the fact that we have an award-winning product, has given us a robust and broad platform to build upon in the year ahead."

Aston Martin Lagonda shares fell 3.9%.

News of seven-time Formula One world champion Lewis Hamilton's switch to Ferrari from Mercedes dominated automotive space chatter last week. Aston Martin Lagonda, is sizing up a personnel change of its own, according to Bloomberg.

A Bloomberg report said Executive Chair Lawrence Stroll has contacted current and former heads of other luxury auto manufacturers to gauge interest in the role, citing people familiar with the matter.

It would mark the fourth change in CEO at the luxury car manufacturer in as many years.

Stroll tapped Felisa, formerly the boss of Ferrari between 2008 and 2016, to be CEO in May 2022. He replaced former Mercedes-AMG boss Tobias Moers, who spent less than two years in the job. His predecessor, Andy Palmer, left months after Stroll rescued Aston Martin in early 2020.

Brent oil was quoted at USD78.57 a barrel at the time of the London equities close on Tuesday, up from USD77.11 late Monday. Gold traded at USD2,036.43 an ounce against USD2,019.86.

Wednesday's economic calendar has a Halifax UK house price index reading and German industrial production data at 0700 GMT.

In the local corporate calendar, housebuilder Barratt Developments and emerging markets-focused asset manager Ashmore release half-year results. Packaging firm Smurfit Kappa reports annual results.

By Eric Cunha, Alliance News news editor

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
21 Oct 2019 15:16

Futura Medical Doses Final Patient In Erectile Dysfunction Drug Study

Futura Medical Doses Final Patient In Erectile Dysfunction Drug Study

Read more
11 Sep 2019 11:21

Futura Medical Shares Drop As Interim Costs Surge Amid Clinical Trial

(Alliance News) - Shares in pharmaceutical firm Futura Medical PLC dropped sharply Wednesday after interim losses worsened amid rising development costs, whilst it continues to progress key in 11%

Read more
24 Jun 2019 09:27

Futura Medical sees 'good progress' despite regulatory delays

(Sharecast News) - Pharmaceutical company Futura Medical told investors at its annual general meeting on Monday that it had continued to make "good progress" in developing and commercialising its pipeline of product opportunities despite regulatory delays to the advancement of its pain relief gel.

Read more
19 Jun 2019 09:58

Futura Medical recruits 1,000 patients for erectile treatment trial

(Sharecast News) - Pharmaceutical company Futura Medical announced the completion of patient recruitment for the first European phase 3 study of MED2005, 'FM57', on Wednesday, adding that it remained on track to deliver headline data by the end of 2019.

Read more
17 Jun 2019 16:02

UK Shareholder Meetings Calendar - Next 7 Days

Tuesday 18 JunePlus500Horizon Discovery GroupClearstarCoca-Cola 19 20 Property (re of

Read more
17 Jun 2019 12:21

Monday broker round-up

(Sharecast News) - Hammerson: Peel Hunt upgrades to add with a target price of 350p.

Read more
10 Apr 2019 11:06

Futura Medical Annual Loss Widens On Higher Research Costs

LONDON (Alliance News) - Futura Medical PLC on Wednesday reported a widened annual loss widened as the company continued to focus on its lead erectile dysfunction treatment MED2005.Futura a

Read more
31 Oct 2018 11:16

Futura Medical Enrol First Patient To Late Stage MED2002 Clinical Test

LONDON (Alliance News) - Pharmaceutical firm Futura Medical PLC said Wednesday it has enrolled its first patient on a late-stage clinical trial of its MED2002 erectile dysfunction is a topical gel

Read more
19 Oct 2018 10:50

WINNERS & LOSERS SUMMARY: Intu Properties Up As Consortium Makes Offer

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Friday.----------FTSE 100 - WINNERS----------London Stock a

Read more
19 Oct 2018 10:30

Futura Medical Shares Drop 27% After Discounted Placing And Open Offer

LONDON (Alliance News) - Shares in Futura Medical PLC plunged on Friday after it said that it raised GBP5.6 million via a share placing, subscription and an open offer at a discounted company 80 7

Read more
18 Oct 2018 17:39

Futura Raising GBP6 Million For Erectile Dysfunction Gel Trial (ALLISS)

LONDON (Alliance News) - Futura Medical PLC on Thursday said it is placing to raise no less than GBP5 million via an accelerated bookbuild and up to an additional GBP1 million through an open will

Read more
26 Sep 2018 16:14

Futura Medical focused on 'excellent' developments as losses deepen

(Sharecast News) - Pharmaceutical group Futura Medical on Wednesday reported an "excellent" first-half as it continued to make progress on the development of two of its main products.

Read more
26 Sep 2018 10:59

Futura Medical Interim Loss Deepens As Revenue Fades, Costs Grow

LONDON (Alliance News) - Healthcare firm Futura Medical PLC said Wednesday its interim loss deepened after revenue disappeared and costs rose, as it continued to make progress on the development 3

Read more
19 Sep 2018 11:40

Futura Medical Shares Down As Phase-Three Data Required For MED2002

LONDON (Alliance News) - Shares in Futura Medical PLC plunged on Wednesday after reporting that potential partners for the licensing of MED2002 have asked for further tests on the product before a

Read more
5 Sep 2018 16:13

UK Earnings, Trading Statements Calendar - Next 7 Days

Thursday 6 September PPHE Hotel GroupHalf Year ResultsHunters PropertyHalf Year Year Year

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.